MALVERN, Pa. & MONTREAL–(BUSINESS WIRE)–Oct 31, 2008 – Gemin X Pharmaceuticals announced today that clinical data from a Phase 1/2 study of obatoclax (GX15-070), the Company’s innovative pan Bcl-2 inhibitor, will be presented during The 26th… Read more…
Many carriers of the potentially lethal Clostridium difficile bug are missed by unreliable tests, researchers say. Read more…
FRIDAY, Oct. 31 — An antibody that breaks down and suppresses an appetite stimulant produced by the human body has been discovered.Scientists with The Scripps Research Institute say the antibody catalyst, GHR-11E11, increased the metabolic rate in… Read more…
RIDGEFIELD, Conn., October 31, 2008 /PRNewswire/ –Results from PRESIDE (valence of Female exual Problems Associated with Dstress and terminants of Treatment Seeking), the largest survey assessing the prevalence of female sexual problems, show that… Read more…
LONDON–(BUSINESS WIRE)–Oct 31, 2008 – Osmetech plc (LSE:OMH), the international molecular diagnostics company announces that Dr. Charles S. Eby, M.D., Associate Professor at the Washington University in St. Louis School of Medicine has presented… Read more…